Literature DB >> 17526018

Activation of epidermal growth factor receptors in astrocytes: from development to neural injury.

Bin Liu1, Arthur H Neufeld.   

Abstract

The epidermal growth factor receptor (EGFR) pathway controls the phenotypic characteristics of astrocytes. In the developing central nervous system (CNS), activation of the EGFR pathway induces astrocyte differentiation, forming the cribriform structure that surrounds axons and providing a supportive environment for neurons. In the adult CNS, the EGFR pathway is absent from astrocytes but is highly up-regulated and activated following neuronal injury. Activation of the EGFR pathway triggers quiescent astrocytes to become reactive astrocytes. Although astrocytes regulated by the EGFR pathway play constructive roles in the developing CNS, astrocytes that become reactive in response to activation of the EGFR pathway appear to be destructive to neurons in the adult CNS. The reappearance and activation of EGFRs in astrocytes under pathological conditions may activate a developmental process in an adult tissue. Regulation of EGFR function in astrocytes may be a new therapeutic strategy for the treatment of neural disorders. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17526018     DOI: 10.1002/jnr.21364

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  33 in total

1.  Hypoxia-induced activation of epidermal growth factor receptor (EGFR) kinase in the cerebral cortex of newborn piglets: the role of nitric oxide.

Authors:  Om Prakash Mishra; Qazi M Ashraf; Maria Delivoria-Papadopoulos
Journal:  Neurochem Res       Date:  2010-06-08       Impact factor: 3.996

2.  Mechanism of CaM kinase IV activation during hypoxia in neuronal nuclei of the cerebral cortex of newborn piglets: the role of Src kinase.

Authors:  Maria Delivoria-Papadopoulos; Qazi M Ashraf; Om Prakash Mishra
Journal:  Neurochem Res       Date:  2011-04-23       Impact factor: 3.996

Review 3.  The astrocyte odyssey.

Authors:  Doris D Wang; Angélique Bordey
Journal:  Prog Neurobiol       Date:  2008-10-01       Impact factor: 11.685

4.  Transforming growth factor α transforms astrocytes to a growth-supportive phenotype after spinal cord injury.

Authors:  Robin E White; Meghan Rao; John C Gensel; Dana M McTigue; Brian K Kaspar; Lyn B Jakeman
Journal:  J Neurosci       Date:  2011-10-19       Impact factor: 6.167

Review 5.  Don't fence me in: harnessing the beneficial roles of astrocytes for spinal cord repair.

Authors:  Robin E White; Lyn B Jakeman
Journal:  Restor Neurol Neurosci       Date:  2008       Impact factor: 2.406

Review 6.  The stem cell potential of glia: lessons from reactive gliosis.

Authors:  Stefanie Robel; Benedikt Berninger; Magdalena Götz
Journal:  Nat Rev Neurosci       Date:  2011-02       Impact factor: 34.870

7.  The EGF epidermal growth factor counteracts Tat modulation of human endogenous retroviruses of the W family in astrocytes.

Authors:  Elena Uleri; Claudia Piu; Maurizio Caocci; Gabriele Ibba; Caterina Serra; Antonina Dolei
Journal:  J Neurovirol       Date:  2017-05-04       Impact factor: 2.643

8.  The Rheb-mTOR pathway is upregulated in reactive astrocytes of the injured spinal cord.

Authors:  Simone Codeluppi; Camilla I Svensson; Michael P Hefferan; Fatima Valencia; Morgan D Silldorff; Masakatsu Oshiro; Martin Marsala; Elena B Pasquale
Journal:  J Neurosci       Date:  2009-01-28       Impact factor: 6.167

9.  Tumorigenicity of cortical astrocyte cell line induced by the protease ADAM17.

Authors:  Mark Katakowski; Feng Jiang; XuGuang Zheng; Jorge A Gutierrez; Alexandra Szalad; Michael Chopp
Journal:  Cancer Sci       Date:  2009-05-18       Impact factor: 6.716

10.  New platform for controlled and sustained delivery of the EGF receptor tyrosine kinase inhibitor AG1478 using poly(lactic-co-glycolic acid) microspheres.

Authors:  Rebecca Robinson; James P Bertram; Jill L Reiter; Erin B Lavik
Journal:  J Microencapsul       Date:  2010-05       Impact factor: 3.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.